569 related articles for article (PubMed ID: 30894182)
21. Tetraspanin CD9 links junctional adhesion molecule-A to αvβ3 integrin to mediate basic fibroblast growth factor-specific angiogenic signaling.
Peddibhotla SS; Brinkmann BF; Kummer D; Tuncay H; Nakayama M; Adams RH; Gerke V; Ebnet K
Mol Biol Cell; 2013 Apr; 24(7):933-44. PubMed ID: 23389628
[TBL] [Abstract][Full Text] [Related]
22. Alternagin-C, a disintegrin-like protein from the venom of Bothrops alternatus, modulates alpha2beta1 integrin-mediated cell adhesion, migration and proliferation.
Selistre-de-Araujo HS; Cominetti MR; Terruggi CH; Mariano-Oliveira A; De Freitas MS; Crepin M; Figueiredo CC; Morandi V
Braz J Med Biol Res; 2005 Oct; 38(10):1505-11. PubMed ID: 16172743
[TBL] [Abstract][Full Text] [Related]
23. The microtubule binding drug laulimalide inhibits vascular endothelial growth factor-induced human endothelial cell migration and is synergistic when combined with docetaxel (taxotere).
Lu H; Murtagh J; Schwartz EL
Mol Pharmacol; 2006 Apr; 69(4):1207-15. PubMed ID: 16415178
[TBL] [Abstract][Full Text] [Related]
24. Vitronectin regulation of vascular endothelial growth factor-mediated angiogenesis.
Li R; Luo M; Ren M; Chen N; Xia J; Deng X; Zeng M; Yan K; Luo T; Wu J
J Vasc Res; 2014; 51(2):110-7. PubMed ID: 24603119
[TBL] [Abstract][Full Text] [Related]
25. Necl-5/poliovirus receptor interacts with VEGFR2 and regulates VEGF-induced angiogenesis.
Kinugasa M; Amano H; Satomi-Kobayashi S; Nakayama K; Miyata M; Kubo Y; Nagamatsu Y; Kurogane Y; Kureha F; Yamana S; Hirata K; Miyoshi J; Takai Y; Rikitake Y
Circ Res; 2012 Mar; 110(5):716-26. PubMed ID: 22282193
[TBL] [Abstract][Full Text] [Related]
26. Acurhagin-C, an ECD disintegrin, inhibits integrin alphavbeta3-mediated human endothelial cell functions by inducing apoptosis via caspase-3 activation.
Wang WJ
Br J Pharmacol; 2010 Jul; 160(6):1338-51. PubMed ID: 20590625
[TBL] [Abstract][Full Text] [Related]
27. An andrographolide derivative AGP-26b exhibiting anti-angiogenic activity in HUVECs and zebrafish via blocking the VEGFA/VEGFR2 signaling pathway.
Huang B; Peng Y; Li J; Li S; Sun Y; Wang D; Yang B; Chan JY; Yu H; Leung GP; Hoi MP; Zhou GC; Lee SM
Mol Biosyst; 2017 Feb; 13(3):525-536. PubMed ID: 28098292
[TBL] [Abstract][Full Text] [Related]
28. EGT022, an RGD-containing recombinant disintegrin, inhibits the VEGF-induced angiogenic process by targeting integrin β3 in endothelial cells.
Kim BK; Lee SJ; Kim TW; Kim H; Lee H; Hong EY; Cho YJ; Kwon S; Kim SH
Am J Transl Res; 2023; 15(3):1831-1841. PubMed ID: 37056800
[TBL] [Abstract][Full Text] [Related]
29. The disintegrin, trimucrin, suppresses LPS-induced activation of phagocytes primarily through blockade of NF-κB and MAPK activation.
Hung YC; Hsu CC; Chung CH; Huang TF
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):723-37. PubMed ID: 27030393
[TBL] [Abstract][Full Text] [Related]
30. Blockage of αvβ3 integrin in 3D culture of triple-negative breast cancer and endothelial cells inhibits migration and discourages endothelial-to-mesenchymal plasticity.
Casali BC; Baptista MP; Pachane BC; Cortez AA; Altei WF; Selistre-de-Araújo HS
Biochem Biophys Rep; 2024 Jul; 38():101686. PubMed ID: 38524278
[TBL] [Abstract][Full Text] [Related]
31. Saxatilin, a snake venom disintegrin, regulates platelet activation associated with human vascular endothelial cell migration and invasion.
Jang YJ; Jeon OH; Kim DS
J Vasc Res; 2007; 44(2):129-37. PubMed ID: 17215584
[TBL] [Abstract][Full Text] [Related]
32. Fc-saxatilin suppresses hypoxia-induced vascular leakage by regulating endothelial occludin expression.
Choi HJ; Kwon I; Kim NE; Kim J; An S; Kang S; Hong SY; Nam HS; Heo JH
Thromb Haemost; 2017 Feb; 117(3):595-605. PubMed ID: 28004056
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory effects of recombinant RTS-jerdostatin on integrin α1β1 function during adhesion, migration and proliferation of rat aortic smooth muscle cells and angiogenesis.
Bolás G; de Rezende FF; Lorente C; Sanz L; Eble JA; Calvete JJ
Toxicon; 2014 Mar; 79():45-54. PubMed ID: 24418176
[TBL] [Abstract][Full Text] [Related]
34. Pleiotrophin selectively binds to vascular endothelial growth factor receptor 2 and inhibits or stimulates cell migration depending on α
Lamprou M; Kastana P; Kofina F; Tzoupis Η; Barmpoutsi S; Sajib MS; Koutsioumpa M; Poimenidi E; Zompra AA; Tassopoulos D; Choleva E; Tselios T; Mikelis CM; Papadimitriou E
Angiogenesis; 2020 Nov; 23(4):621-636. PubMed ID: 32681389
[TBL] [Abstract][Full Text] [Related]
35. FAS1 domain protein inhibits VEGF165-induced angiogenesis by targeting the interaction between VEGFR-2 and αvβ3 integrin.
Nam JO; Son HN; Jun E; Cha K; Lee BH; Park RW; Kim IS
Mol Cancer Res; 2012 Aug; 10(8):1010-20. PubMed ID: 22710795
[TBL] [Abstract][Full Text] [Related]
36. The anti-angiogenic action of 2-deoxyglucose involves attenuation of VEGFR2 signaling and MMP-2 expression in HUVECs.
Chuang IC; Yang CM; Song TY; Yang NC; Hu ML
Life Sci; 2015 Oct; 139():52-61. PubMed ID: 26285173
[TBL] [Abstract][Full Text] [Related]
37. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
38. Domain I-IV of β2-glycoprotein I inhibits advanced glycation end product-induced angiogenesis by down-regulating vascular endothelial growth factor 2 signaling.
Wang QQ; Zhou SJ; Meng ZX; Wang J; Chen R; Lv L; Li CJ; Yu DM; Yu P
Mol Med Rep; 2015 Mar; 11(3):2167-72. PubMed ID: 25405610
[TBL] [Abstract][Full Text] [Related]
39. Antitumoral Potential of Lansbermin-I, a Novel Disintegrin from Porthidium lansbergii lansbergii Venom on Breast Cancer Cells.
Montealegre-Sánchez L; Gimenes SNC; Lopes DS; Teixeira SC; Solano-Redondo L; de Melo Rodrigues V; Jiménez-Charris E
Curr Top Med Chem; 2019; 19(22):2069-2078. PubMed ID: 31385773
[TBL] [Abstract][Full Text] [Related]
40. Thyroid hormone induced angiogenesis through the integrin αvβ3/protein kinase D/histone deacetylase 5 signaling pathway.
Liu X; Zheng N; Shi YN; Yuan J; Li L
J Mol Endocrinol; 2014 Jun; 52(3):245-54. PubMed ID: 24532656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
